TSE:TRIL

23.33
0.11 (0.47%) 1d
0

Related posts

Oil and Pfizer approval lift Monday marketsBiogen soars amid flat marketsKinross Gold, Northland Power Inc and More at 52-week Highs (Sep 16-22)
COMMENT

Pfizer bought it today, and TRIL shares tripled from $6 to $18 in the blink of an eye. That's why he always advises investing in small drug companies; sometimes they pan out.

Consumer Products
HOLD
(Market Call Minute.) Volatile stock and you can hold it if it hangs in there but be careful.
Consumer Products
WATCH
Fascinated by the technology, they’re taking 2 off patent drugs and combining them to use in therapy for stroke victims. Has a lot of potential. Still has some huge upside.
Consumer Products
Showing 1 to 3 of 3 entries
  • «
  • 1
  • »

Trillium Therapeutics Inc(TRIL-T) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Trillium Therapeutics Inc is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Trillium Therapeutics Inc(TRIL-T) Frequently Asked Questions

What is Trillium Therapeutics Inc stock symbol?

Trillium Therapeutics Inc is a Canadian stock, trading under the symbol TRIL-T on the Toronto Stock Exchange (TRIL-CT). It is usually referred to as TSX:TRIL or TRIL-T

Is Trillium Therapeutics Inc a buy or a sell?

In the last year, there was no coverage of Trillium Therapeutics Inc published on Stockchase.

Is Trillium Therapeutics Inc a good investment or a top pick?

Trillium Therapeutics Inc was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Trillium Therapeutics Inc.

Why is Trillium Therapeutics Inc stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Trillium Therapeutics Inc worth watching?

0 stock analysts on Stockchase covered Trillium Therapeutics Inc In the last year. It is a trending stock that is worth watching.

What is Trillium Therapeutics Inc stock price?

On 2021-11-19, Trillium Therapeutics Inc (TRIL-T) stock closed at a price of $23.33.